|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||3.9920 - 3.9920|
|52-week range||3.9920 - 3.9920|
|Beta (5Y monthly)||2.42|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2021 - 12 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Amplify Seymour Cannabis ETF (CNBS) topped the list of the best-performing ETFs of February with impressive returns of about 60%.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Zynerba Pharmaceuticals (ZYNE) closed at $4.15 in the latest trading session, marking a +1.47% move from the prior day.